Getting Connected: The Benefits of a Unified Clinical Platform

Jan 8, 2018

For nearly 20 years the issue of disconnected, poorly integrated systems and processes has hampered clinical R&D. The problem and its challenges have been discussed and dissected, and has been top of mind of clinical operations leaders. The constant and critical push to accelerate a product’s time to market continues to push clinical teams to seek solutions that deliver greater efficiencies.  But after 20 years of point-to-point integrations, the time has come for a different, unified approach. Download this white paper to learn more about a unified clinical platform:
  • Changing dynamics and their impact on today’s clinical teams
  • The benefits to be gained, spanning both clinical operations and clinical data management
  • Available new technologies and how they are transform and offer a progressive approach for overcoming today’s clinical trial complexities
[contact-form-7 id="41" title="download the White Paper Default"]

About ArisGlobal

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary Nava® cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China. For more updates, follow ArisGlobal on LinkedIn and Twitter.

Additional Information

Connect with ArisGlobal on LinkedIn:
Follow @Aris_Global on Twitter:


Alberto Cantor
+1 609-360-4042 |